I am a board-certified medical oncologist. My clinical practice is focused on the care of women with gynecologic cancers, and I have a special expertise in treating uterine sarcomas. I have been on the attending staff at Memorial Sloan Kettering since 1998, working as part of a multidisciplinary team dedicated to caring for women with these diseases.
My clinical research is focused on developing novel treatments and improving treatment strategies for women with recurrent ovarian cancer or uterine sarcomas (leiomyosarcoma, carcinosarcoma, high grade undifferentiated sarcomas, endometrial stromal sarcomas, and others. I serve as principal investigator for several national and international research studies in these areas. I also have an interest in patient-reported outcomes, including quality-of-life issues, related to cancer treatments.
In addition to serving on committees of the Gynecologic Oncology Group devoted to the research of health-related outcomes and novel drug development for uterine cancers, I am active in the Sarcoma Alliance for Research through Collaboration. This consortium facilitates research collaborations among sarcoma specialists.
I earned my medical degree at Duke University School of Medicine, completed residency and oncology fellowship training at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and completed a master’s degree in epidemiology at the Harvard School of Public Health.
- Clinical Expertise: Ovarian Cancer; Endometrial Cancer; Uterine Sarcomas; Cervical Cancer
- Languages Spoken: English
- Education: MD, Duke University School of Medicine
- Residencies: The New York Hospital-Cornell Medical Center
- Fellowships: The New York Hospital-Cornell Medical Center
- Board Certifications: Medical Oncology; Hematology
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.